InMed Pharmaceuticals – Unlocking the Potential of Cannabinoids in the Medical Space

In this health supplier segment, Josh Blacher, Chief Business Officer at Inmed Pharmaceuticals, a biopharmaceutical company, discusses the potential that understudied cannabinoids can have in the medical space, as well as current trends in the industry.

Listen to more #podcast episode at www.hpr.fm

source